Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial (2022)
Attributed to:
New Branched Polymers Excipients and Emulsions for Enhanced Drug Delivery
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ebiom.2022.104322
PubMed Identifier: 36332361
Publication URI: http://europepmc.org/abstract/MED/36332361
Type: Journal Article/Review
Parent Publication: eBioMedicine
ISSN: 2352-3964